Results 11 to 20 of about 14,471,607 (152)

STUDY OF DES-GAMMA-CARBOXYPROTHROMBIN (DCP) LEVELS IN CHRONIC HEPATITIS C WITH OR WITHOUT HEPATOCELLULAR CARCINOMA (HCC) IN EGYPTIAN PATIENTS [PDF]

open access: yesAl-Azhar Journal of Pharmaceutical Sciences, 2015
Hepatocellular carcinoma (HCC) is usually asymptomatic in the early stage and does not show elevated alpha-feto protein (AFP). Des-Gamma-CarboxyProthrombin (DCP) and Carbohydrate antigen 19-9 (CA19-9) may increase in sera of HCC patients.
Omnia Kamel
doaj   +9 more sources

Utility of serum des-gamma-carboxyprothrombin in the diagnosis of hepatocellular carcinoma among Nigerians, a case-control study. [PDF]

open access: yesBMC Gastroenterol, 2015
Hepatocellular Carcinoma (HCC) is a common malignancy occurring globally but with a dismal prognosis. Des-gamma-carboxyprothrombin (DCP) has been reported to be more sensitive and specific than Alpha-fetoprotein (AFP) in the diagnosis of HCC among the White population. Its efficacy among the Black population is yet to be established.
Ette AI   +3 more
europepmc   +5 more sources

Diagnostic Utility of Alpha‑fetoprotein and Des‑gamma‑carboxyprothrombin in Nigerians with Hepatocellular Carcinoma [PDF]

open access: yesNigerian Journal of Clinical Practice, 2017
Background: Alpha-fetoprotein (AFP) and Des-gamma-carboxyprothrombin (DCP) have been extensively studied as biomarkers for the diagnosis of and prognostication in hepatocellular carcinoma (HCC).
Ndububa, DA   +3 more
core   +5 more sources

Serum des-gamma-carboxyprothrombin in patients with pancreatic head adenocarcinoma

open access: yesBratislavske lekarske listy, 2011
The total des-gamma-carboxyprothrombin (DCP) produced in pancreatic adenocarcinoma and the correlation between the tissue DCP and serum DCP levels has been examined.
Kemik, A. S.   +3 more
core   +5 more sources

Development and Validation of a Prognostic Nomogram for Patients with AFP and DCP Double-Negative Hepatocellular Carcinoma After Local Ablation [PDF]

open access: yesJournal of Hepatocellular Carcinoma
Wenying Qiao,1– 3,* Jiashuo Li,2,* Qi Wang,2,* Ronghua Jin,2,3 Honghai Zhang1 1Interventional Therapy Center for Oncology, Beijing You’an Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Beijing Di’tan Hospital ...
Qiao W, Li J, Wang Q, Jin R, Zhang H
doaj   +2 more sources

The Impact of TP53-Induced Glycolysis and Apoptosis Regulator on Prognosis in Hepatocellular Carcinoma: Association with Tumor Microenvironment and Ferroptosis [PDF]

open access: yesLiver Cancer
Introduction: TP53-induced glycolysis and apoptosis regulator (TIGAR) is a p53 target protein that has critical roles in glycolysis and redox balance. The reports about the effect of TIGAR on prognosis and its biological role in hepatocellular carcinoma (
Katsuya Toshida   +12 more
doaj   +2 more sources

Experimental Measurements and Computer Simulation of Fission Product Gamma-Ray Spectra [PDF]

open access: yes, 1997
Airborne gamma ray spectrometry using high volume scintillation detectors, optionally in conjunction with Ge detectors, has potential for making rapid environmental measurements in response to nuclear accidents. An experimental investigation and computer
Sanderson, D.C.W.   +4 more
core   +8 more sources

ASSESSMENT OF THE VALUE OF MEAN PLATELET VOLUME, DES GAMMA CARBOXY PROTHROMBIN AND ALPHA FETO PROTEIN IN EARLY DETECTION OF HCC [PDF]

open access: yesAin Shams Medical Journal, 2022
Background: Hepatocellular carcinoma (HCC) is the commonest primary hepatic neoplasm. The gold standard HCC biomarker is alfa-feto protein (AFP), also mean platelet volume (MPV) is increased in many inflammatory disorders and numerous neoplasms.
Omnia Ellaithy   +3 more
doaj   +1 more source

Combining des-gamma-carboxyprothrombin and alpha-fetoprotein for hepatocellular carcinoma diagnosing: an update meta-analysis and validation study. [PDF]

open access: yesOncotarget, 2017
Controversies about the combination of des-gamma-carboxyprothrombin (DCP) and alpha-fetoprotein (AFP) for hepatocellular carcinoma diagnosing still exist. Hence, we performed this updated meta-analysis to estimate the diagnostic value of DCP , AFP and DCP + AFP in HCC.
Chen H   +9 more
europepmc   +4 more sources

MicroRNA-26a systemic administration attenuates tumor formation in hepatocellular carcinoma mouse model

open access: yesPakistan Journal of Pharmaceutical Sciences, 2021
MicroRNA (miRNA)-26a is one of the tumor suppressor genes that has been down regulated during the development of hepatocellular carcinoma (HCC). This work was conducted to evaluate the possible preventive effect of exogenous miRNA-26a administration on ...
Abeer M. Badr   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy